Shares of RxSight, Inc. (NASDAQ: RXST) rose sharply during Monday’s session after the company issued preliminary FY23 and FY24 revenue guidance above estimates.
Also, Needham maintained a Buy rating on the stock and raised its price target from $35 to $41.
Northern Dynasty Minerals Ltd. (TSX:NDM)(NYSE:NAK) ("Northern Dynasty" or the "Company") reports that the US Supreme Court has denied Alaska's petition to review its claims that the EPA veto of the Pebble Project was
Northern Dynasty Minerals Ltd. (TSX:NDM);(NYSE:NAK) ("Northern Dynasty" or the "Company") reports it has received an initial $2 million royalty investment under the second tranche investment of the Company's royalty
Gainers
Palisade Bio, Inc. (NASDAQ: PALI) shares jumped 114% to $1.47. Palisade Bio transformed GI-focused pipeline through exclusive worldwide licensing agreement with Giiant Pharma, Inc. for multiple oral drug candidates targeting inflammatory bowel disease.
- Form 6 Filing
Northern Dynasty prepared its Financial Statements on the basis that Northern Dynasty will continue as a going concern. At March 31, 2023, the Company had working capital
Northern Dynasty Minerals (AMEX:NAK) reported quarterly losses of $(0.01) per share. This is a 60 percent increase over losses of $(0.02) per share from the same period last year.